Mipsagargin Uses, Dosage, Side Effects and more
Mipsagargin has been used in trials studying the treatment of Prostate Cancer, Prostatic Neoplasms, Advanced Solid Tumors, Glioblastoma Multiforme, and Hepatocellular Carcinoma, among others.
| Trade Name | Mipsagargin |
| Generic | Mipsagargin |
| Mipsagargin Other Names | Mipsagargin |
| Type | |
| Formula | C66H100N6O27 |
| Weight | Average: 1409.541 Monoisotopic: 1408.663641984 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
